We are a research-based specialty
biopharma company determined
to give people worldwide a longer
and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more

R&D

Scandinavian Biopharma

Scandinavian Biopharma secures €10.6 million from EDCTP for a Phase III trial of ETVAX® in children in low- and middle-income countries

Scandinavian Biopharma has been awarded a €10.6 million grant from EDCTP in international competition for the planned Phase III clinical trial of the ETEC vaccine candidate ETVAX®. The EDCTP grant is a part of the European Framework Programme[...]
Read more

Distribution

Scandinavian Biopharma

Scandinavian Biopharma expands its Nordic vaccine business with the oral typhoid vaccine Vivotif®

Scandinavian Biopharma has entered into a Nordic distribution agreement with Emergent Travel Health for the oral typhoid vaccine Vivotif®. Typhoid fever is a severe and potentially life-threatening infection caused by the Salmonella bacteria. [...]
Read more